These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3887552)

  • 1. The influence of jejunoileal ratio on plasma electrolytes and liver function in intestinal bypass for morbid obesity. A randomized trial.
    Håkansson T; Andersen B; Christensen RF; Christensen S
    Scand J Gastroenterol; 1985 Mar; 20(2):179-82. PubMed ID: 3887552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total plasma cholesterol in obesity after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio. A randomized trial.
    Sørensen TI; Andersen B; Kam-Hansen L
    Scand J Gastroenterol; 1979; 14(7):865-8. PubMed ID: 395631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised trial of jejunoileal bypass versus medical treatment in morbid obesity. The Danish Obesity Project.
    Lancet; 1979 Dec; 2(8155):1255-8. PubMed ID: 93179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels and clearance of bile acids are unaffected by jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
    Sørensen TI; Bruusgaard A; Nyboe Andersen A; Andersen B
    Scand J Gastroenterol; 1981; 16(6):705-11. PubMed ID: 7323704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jejunoileal bypass for morbid obesity. A critical appraisal.
    Halverson JD; Wise L; Wazna MF; Ballinger WF
    Am J Med; 1978 Mar; 64(3):461-75. PubMed ID: 345803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial of jejunoileal and gastric bypass for the treatment of morbid obesity: four-year progress report.
    Buckwalter JA
    Am Surg; 1980 Jul; 46(7):377-81. PubMed ID: 7004288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in plasma mineral levels after jejunoileal bypass (author's transl)].
    Rozhold J; Beno I; Siman J; Príkazská M; Horváth A; Hermann H
    Bratisl Lek Listy; 1979 May; 71(5):530-8. PubMed ID: 445204
    [No Abstract]   [Full Text] [Related]  

  • 8. Gut and pancreatic hormones after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
    Sørensen TI; Lauritsen KB; Holst JJ; Stadil F; Andersen B
    Digestion; 1983; 26(3):137-45. PubMed ID: 6343164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of gallstone formation after jejunoileal bypass increases more with a 1:3 than with a 3:1 jejunoileal ratio.
    Sørensen TI; Ingemann Jensen L; Klein HC; Andersen B; Petersen O; Laursen K; Danø P; Nielsen OV
    Scand J Gastroenterol; 1980; 15(8):979-84. PubMed ID: 7233072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome after jejunoileal bypass for morbid obesity.
    Mustajoki P; Lempinen M; Huikuri K; Pelkonen R; Nikkilä E
    Int J Obes; 1984; 8(4):319-25. PubMed ID: 6511168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of jejunoileal bypass in two hundred patients with morbid obesity.
    Scott HW; Dean RH; Shull HJ; Gluck F
    Surg Gynecol Obstet; 1977 Nov; 145(5):661-73. PubMed ID: 910208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric and jejunoileal bypass. A comparison in the treatment of morbid obesity.
    Alden JF
    Arch Surg; 1977 Jul; 112(7):799-806. PubMed ID: 880023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity.
    Griffen WO; Young VL; Stevenson CC
    Ann Surg; 1977 Oct; 186(4):500-9. PubMed ID: 907395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal bypass. A randomized, prospective clinical study of end-to-side and end-to-end jejunoileal bypass.
    Viddal KO
    Scand J Gastroenterol; 1983 Jul; 18(5):627-34. PubMed ID: 6675183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jejunoileal bypass for the treatment of morbid obesity.
    Buchwald H
    Int Surg; 1980; 65(2):103-5. PubMed ID: 7216653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid malabsorption after jejunoileal bypass is less compensated for with a 1:3 than with a 3:1 jejunoileal ratio.
    Sørensen TI; Bruusgaard A; Andersen B
    Scand J Gastroenterol; 1982 Jun; 17(4):473-80. PubMed ID: 7134874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Night blindness and liver cirrhosis as late complications of jejunoileal bypass surgery for morbid obesity.
    Enat R; Nagler A; Bassan L; Perlman I; Kanter Y; Schramek A; Barzilai D
    Isr J Med Sci; 1984 Jun; 20(6):543-6. PubMed ID: 6332098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional adaptation of the intestinal mucosal enzymes after jejunoileal bypass for morbid obesity.
    Stein TA; Wise L
    Am J Clin Nutr; 1978 Jul; 31(7):1143-8. PubMed ID: 665564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mucosal response in the excluded limb after jejunoileal bypass for morbid obesity.
    Friedman HI; Villar HV; Nemeth TJ
    Surg Gynecol Obstet; 1981 Sep; 153(3):346-50. PubMed ID: 7268609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cholesterol fractions after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
    Sørensen TI; Andersen B; Damgaard-Pedersen F
    Scand J Gastroenterol; 1982 Mar; 17(2):199-203. PubMed ID: 7134845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.